glp 1 agonist and alcohol A preliminary study of the physiological perceptual effects of GLP-1 receptor agonists during consumption in people with obesity Pleiotropic effects of systemic administration

J., Lee, K

Side effect comparison NSAIDs (Ibuprofen, Naproxen, etc.): Stomach ulcers and bleeding Kidney damage (long-term) Increased heart attack risk Liver stress Opioids: Addiction and dependence Constipation Sedation and cognitive effects Overdose risk Peptides (BPC-157, TB-500, KPV): Minimal side effects Rare: mild headache, fatigue (temporary) No addiction potential No organ damage Safe long-term use Clear winner: Peptides far safer for chronic pain management

Aim for at least 30 minutes of moderate exercise most days of the week

Regeneration or Risk

Ultimately, this research strives to contribute to an innovative, physiology-based approach to health care for individuals with T21